ALKERMES | ALKS - Kapitalisasi Pasar





Kapitalisasi Pasar Perubahan Tanggal
AbbVie USD 444.6B 59.91B 2026-06
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
ALKERMES USD 8.73B 2.85B 2026-06
Amgen USD 195.44B 5.55B 2026-06
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 1.13T 260.54B 2026-06
Gilead Sciences USD 156.86B 16.13B 2026-06
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
J&J USD 611.36B 32.21B 2026-06
Malin Corporation EUR 133.52M 29.05M 2026-08
Merck USD 317.37B 20.27B 2026-06
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Otsuka Holdings JPY 5.87T 111.31B 2026-06
Ovoca Bio EUR 1.17M 18.38K 2025-12
Pfizer USD 138.44B 15.37B 2026-06
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06